News Focus
News Focus
Post# of 257391
Next 10
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

Re: DewDiligence post# 250519

Monday, 02/05/2024 9:54:12 PM

Monday, February 05, 2024 9:54:12 PM

Post# of 257391
25M for tafasitamab is a pretty good deal. Consider if tafasitamab is successful in first line DLBCL and second line lymphoma, INCY will have to pay MOR 500M in milestone.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today